CURIS, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
CURIS, INC. (CRIS) had Warrants Not Settleable in Cash, Fair Value Disclosure of $615.86 thousand as of 2012-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2015-02-24
- 2012-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $615.86K.
- 2011-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $4.36M.
- 2010-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $1.60M.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2012-12-31 | $615.86K 10-K · filed 2015-02-24 |
| 2011-12-31 | $4.36M 10-K · filed 2013-03-13 |
| 2010-12-31 | $1.60M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |